These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

734 related articles for article (PubMed ID: 28356734)

  • 1. Therapeutic effects of proteoliposomes on X-linked chronic granulomatous disease: proof of concept using macrophages differentiated from patient-specific induced pluripotent stem cells.
    Brault J; Vaganay G; Le Roy A; Lenormand JL; Cortes S; Stasia MJ
    Int J Nanomedicine; 2017; 12():2161-2177. PubMed ID: 28356734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular aspects of chronic granulomatous disease. "the NADPH oxidase complex"].
    Morel F
    Bull Acad Natl Med; 2007 Feb; 191(2):377-90; discussion 390-2. PubMed ID: 17969555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NOX4 is the main NADPH oxidase involved in the early stages of hematopoietic differentiation from human induced pluripotent stem cells.
    Brault J; Vigne B; Meunier M; Beaumel S; Mollin M; Park S; Stasia MJ
    Free Radic Biol Med; 2020 Jan; 146():107-118. PubMed ID: 31626946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three novel mutations in CYBA among 22 Iranians with Chronic granulomatous disease.
    Badalzadeh M; Tajik S; Fazlollahi MR; Houshmand M; Fattahi F; Alizadeh Z; Movahedi M; Adab Z; Khotaei GT; Hamidieh AA; Heidarnazhad H; Pourpak Z
    Int J Immunogenet; 2017 Dec; 44(6):314-321. PubMed ID: 28941186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil nicotinamide adenine dinucleotide phosphate oxidase assembly. Translocation of p47-phox and p67-phox requires interaction between p47-phox and cytochrome b558.
    Heyworth PG; Curnutte JT; Nauseef WM; Volpp BD; Pearson DW; Rosen H; Clark RA
    J Clin Invest; 1991 Jan; 87(1):352-6. PubMed ID: 1985107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.
    Köker MY; Camcıoğlu Y; van Leeuwen K; Kılıç SŞ; Barlan I; Yılmaz M; Metin A; de Boer M; Avcılar H; Patıroğlu T; Yıldıran A; Yeğin O; Tezcan I; Sanal Ö; Roos D
    J Allergy Clin Immunol; 2013 Nov; 132(5):1156-1163.e5. PubMed ID: 23910690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementation of NADPH oxidase in p67-phox-deficient CGD patients p67-phox/p40-phox interaction.
    Vergnaud S; Paclet MH; El Benna J; Pocidalo MA; Morel F
    Eur J Biochem; 2000 Feb; 267(4):1059-67. PubMed ID: 10672014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Modalities Based on Flow Cytometry for Chronic Granulomatous Disease: A Multicenter Study in a Well-Defined Cohort.
    Baris HE; Ogulur I; Akcam B; Kiykim A; Karagoz D; Saraymen B; Akgun G; Eltan SB; Aydemir S; Akidagi Z; Bentli E; Nain E; Kasap N; Baser D; Altintas DU; Camcioglu Y; Yesil G; Ozen A; Koker MY; Karakoc-Aydiner E; Baris S
    J Allergy Clin Immunol Pract; 2020; 8(10):3525-3534.e1. PubMed ID: 32736065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized Generation of Functional Neutrophils and Macrophages from Patient-Specific Induced Pluripotent Stem Cells: Ex Vivo Models of X(0)-Linked, AR22(0)- and AR47(0)- Chronic Granulomatous Diseases.
    Brault J; Goutagny E; Telugu N; Shao K; Baquié M; Satre V; Coutton C; Grunwald D; Brion JP; Barlogis V; Stephan JL; Plantaz D; Hescheler J; Krause KH; Sarić T; Stasia MJ
    Biores Open Access; 2014 Dec; 3(6):311-26. PubMed ID: 25469316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte/macrophage-specific NADPH oxidase contributes to antimicrobial host defense in X-CGD.
    Okura Y; Yamada M; Kuribayashi F; Kobayashi I; Ariga T
    J Clin Immunol; 2015 Feb; 35(2):158-67. PubMed ID: 25666294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Derivation and functional analysis of patient-specific induced pluripotent stem cells as an in vitro model of chronic granulomatous disease.
    Jiang Y; Cowley SA; Siler U; Melguizo D; Tilgner K; Browne C; Dewilton A; Przyborski S; Saretzki G; James WS; Seger RA; Reichenbach J; Lako M; Armstrong L
    Stem Cells; 2012 Apr; 30(4):599-611. PubMed ID: 22311747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematologically important mutations: The autosomal forms of chronic granulomatous disease (third update).
    Roos D; van Leeuwen K; Hsu AP; Priel DL; Begtrup A; Brandon R; Rawat A; Vignesh P; Madkaikar M; Stasia MJ; Bakri FG; de Boer M; Roesler J; Köker N; Köker MY; Jakobsen M; Bustamante J; Garcia-Morato MB; Shephard JLV; Cagdas D; Tezcan I; Sherkat R; Mortaz E; Fayezi A; Shahrooei M; Wolach B; Blancas-Galicia L; Kanegane H; Kawai T; Condino-Neto A; Vihinen M; Zerbe CS; Holland SM; Malech HL; Gallin JI; Kuhns DB
    Blood Cells Mol Dis; 2021 Dec; 92():102596. PubMed ID: 34547651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox.
    Leusen JH; de Boer M; Bolscher BG; Hilarius PM; Weening RS; Ochs HD; Roos D; Verhoeven AJ
    J Clin Invest; 1994 May; 93(5):2120-6. PubMed ID: 8182143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variants in nicotinamide adenine dinucleotide phosphate oxidase complex components determine susceptibility to very early onset inflammatory bowel disease.
    Dhillon SS; Fattouh R; Elkadri A; Xu W; Murchie R; Walters T; Guo C; Mack D; Huynh HQ; Baksh S; Silverberg MS; Griffiths AM; Snapper SB; Brumell JH; Muise AM
    Gastroenterology; 2014 Sep; 147(3):680-689.e2. PubMed ID: 24931457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Missense mutations in the gp91-phox gene encoding cytochrome b558 in patients with cytochrome b positive and negative X-linked chronic granulomatous disease.
    Kaneda M; Sakuraba H; Ohtake A; Nishida A; Kiryu C; Kakinuma K
    Blood; 1999 Mar; 93(6):2098-104. PubMed ID: 10068684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay.
    Jirapongsananuruk O; Malech HL; Kuhns DB; Niemela JE; Brown MR; Anderson-Cohen M; Fleisher TA
    J Allergy Clin Immunol; 2003 Feb; 111(2):374-9. PubMed ID: 12589359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioluminescence imaging of NADPH oxidase activity in different animal models.
    Han W; Li H; Segal BH; Blackwell TS
    J Vis Exp; 2012 Oct; (68):. PubMed ID: 23117583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two X-linked chronic granulomatous disease patients with unusual NADPH oxidase properties.
    Wolach B; Broides A; Zeeli T; Gavrieli R; de Boer M; van Leeuwen K; Levy J; Roos D
    J Clin Immunol; 2011 Aug; 31(4):560-6. PubMed ID: 21604087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-Free NADPH Oxidase Activation Assays: A Triumph of Reductionism.
    Pick E
    Methods Mol Biol; 2020; 2087():325-411. PubMed ID: 31729001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of NOX2 into a constitutive enzyme in vitro and in living cells, after its binding with a chimera of the regulatory subunits.
    Masoud R; Serfaty X; Erard M; Machillot P; Karimi G; Hudik E; Wien F; Baciou L; Houée-Levin C; Bizouarn T
    Free Radic Biol Med; 2017 Dec; 113():470-477. PubMed ID: 29079525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.